The Serum Institute of India has partnered with the AstraZeneca company to manufacture the Oxford Corona vaccine in the country. It is named ‘Kovishield’. The vaccine has been developed by AstraZeneca and the University of Oxford. It will be mass-produced in India. The vaccine has been developed by the UK and will be manufactured in India. Adar Poonawala is the CEO of the Serum Institute of India. Coronavirus Vaccine Kovishield will cost less than Rs 1,000.
For vaccine testing in India, each patient will be given two doses after a safety and immunological assessment. Recently, Adar Poonawala, CEO of Serum Institute of India said that we will start testing in the country as soon as we get the approval for the test. At the same time, large-scale vaccine production will begin.
Will produce 500 doses of vaccine per minute. The Serum Institute will initially focus on making 40–50 lakh vaccine doses per month, but will later increase it to 35–40 million vaccine doses. The cost of Oxford vaccine in India will be extremely low.
The vaccine will be distributed on a 50 percent basis between India and the rest of the world. can do. Recently it was claimed that if the vaccine becomes available in the market by the end of this year, everything will be fine.